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Abstract 
Background: Bicarbonate-based peritoneal dialysis (PD) fluids enhance the migratory capacity and damage-repair 
ability of human peritoneal mesothelial cells by upregulating AQP1. However, little is known about the underlying 
molecular mechanisms.
Results: Here we used HEK-293T cells to investigate the effect of pH on AQP1 gene transcription levels. We found 
that AQP1 mRNA levels increases with pH. Transfection of HEK-293T cells with luciferase reporter vectors contain-
ing different regions of the AQP1 promoter identified an upstream region in the AQP1 gene between − 2200 and 
– 2300 bp as an enhancer required for pH-mediated regulation of AQP1 expression. Site-directed mutagenesis of this 
specific promoter region revealed a critical region between − 2257 and − 2251 bp, and gene knock-down experi-
ments and ChIP assays suggested that the Spi-B transcription factor SPIB is involved in pH-mediated regulation of 
AQP1 expression.
Conclusions: We identified an upstream region in the AQP1 gene and the transcription factor SPIB that are critically 
involved in pH-mediated regulation of AQP1 expression. These findings provide the basis for further studies on the 
pH- and buffer-dependent effects of PD fluids on peritoneal membrane integrity and function.
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Background
End-stage renal disease (ESRD) has a poor prognosis and 
affects human populations around the world [1]. Perito-
neal dialysis (PD) is a well-established renal replacement 
therapy that takes advantage of the semi-permeability of 
the peritoneal membrane, to remove toxins and excess 
water from the circulatory system. Maintenance of the 
morphological and functional integrity of the peritoneum 
is essential for long-term PD patients. However, conven-
tional acidic PD solutions cause peritoneal cell damage, 
cell shedding [2–4], peritoneal fibrosis and progressive 
vascularization [5–8], leading to ultrafiltration loss and 
eventually PD failure [9].
Novel PD solutions that separate glucose from the 
buffer at a very low pH contain fewer glucose degrada-
tion products (GDPs) and have a neutral to physiologi-
cal pH after mixing. Several studies suggest that these 
solutions can reduce peritoneal cell damage and preserve 
the peritoneal membrane host defence and transport 
functions. The solutions contain lactate, bicarbonate or 
a mixture of both buffers. A prospective paediatric trial 
that compared a pure bicarbonate buffer to a purely 
lactate-based low GDP fluid demonstrated better pres-
ervation of ultrafiltration capacity over 10  months [10]. 
However, the underlying mechanisms remained elu-
sive, and the respective impacts of the solutions on cel-
lular pH are unknown. The ultrafiltration capacity of the 
peritoneum is closely related to peritoneal aquaporin 1 
(AQP1) expression. AQP1 is expressed in peritoneal cap-
illaries, post-capillary venules and peritoneal mesothelial 
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cells, which are critical for maintaining local peritoneal 
homeostasis [11–13]. AQP1 knockout mice have approx-
imately 50% less peritoneal ultrafiltration capacity [14, 
15]. Previously, via in  vitro experiments, we demon-
strated pH and buffer dependent upregulation of AQP1 
in human peritoneal mesothelial cells and improved 
AQP1-dependent cell migration. Actinomycin D-based 
experiments further demonstrated that the pH-mediated 
effects on AQP1 occurred at the transcriptional level 
[16]. Differences in the PD fluid buffer and pH may there-
fore play an important role through regulation of AQP1 
gene expression.
Thus, here, we examined the underlying molecular 
mechanisms of pH- and buffer-dependent AQP1 expres-
sion in HEK-293T cells, which display reliable growth 
and have a propensity for transfection. We extensively 
explored the key transcription factors and their bind-
ing sites involved in pH-mediated regulation of AQP1 
expression by cloning the AQP1 gene promoter region 
and various truncated forms of the promoter region.
Materials and methods
Plasmids and reagents
A Flag-tagged SPIB expression clone and the vector plas-
mid were purchased from GeneCopoeia (Guangzhou, 
China). Anti-IgG and anti-SPIB antibodies were pur-
chased from Cell Signaling Technology, and anti-Flag and 
anti-β-actin antibodies were obtained from Sigma.
Cell culture
The HEK-293T cell line was purchased from ATCC 
(American Type Culture Collection). HEK-293T cells 
were cultured at 37  °C with 5%  CO2 in DMEM supple-
mented with 10% foetal bovine serum and transfected 
using Lipofectamine 2000 reagent (Invitrogen) according 
to the manufacturer’s instructions. The total amount of 
plasmid DNA used for transfection was maintained at a 
constant level between experimental conditions through 
the addition of empty vector plasmid. To investigate 
the regulatory effects of pH on AQP1 gene expression, 
HEK-293T cells were seeded into 6-well plates. Once the 
cells attached to the culture surface, the regular culture 
medium was replaced with serum-free culture medium, 
and the cells were cultured in the serum-free medium 
for 24 h. Subsequently, the cells were treated with bicar-
bonate-buffered complete media in which the pH was 
adjusted to 6, 7 or 8 with HCl or NaOH. After treatment 
for 24 h, the cells were lysed.
RNA extraction and real‑time PCR analysis
Total cellular RNA was extracted using Trizol reagent 
(Invitrogen Corporation). In total, 500  ng of RNA was 
reverse transcribed into cDNA using a PrimeScript 
Reverse Transcription Kit (Takara Biotechnology Co., 
Ltd); β-actin was used as an internal reference. The 
sequences of the specific primers for quantitative poly-
merase chain reaction (qPCR) were listed in Additional 
file  1: Table S1. The relative expression levels of target 
genes were calculated using the  2−ΔΔCT method.
Western blot analysis
Cells were harvested by scraping into an SDS sample 
buffer. Similar protein amounts were loaded onto a 7.5% 
SDS-PAGE gel, separated by electrophoresis, and trans-
ferred to a nitrocellulose membrane (Bio-Rad, Hercu-
les, CA). The membrane was blocked with TBST (0.05% 
Tween 20 in TBS) containing 5% skim milk and then 
incubated overnight with the indicated antibodies at 4 °C. 
The membrane was washed three times in TBST and 
then incubated with an HRP-conjugated secondary anti-
body (Pierce, Rockford, IL) (1:2000) for 2 h at room tem-
perature. The membranes were stripped of the primary 
antibodies and reprobed with antibodies as necessary. 
The immunocomplexes were detected using enhanced 
chemiluminescence (Pierce, Rockford, IL, USA).
Dual‑luciferase reporter vector construction
Genomic DNA was extracted from HEK-293T cells using 
an AllPrep DNA/RNA Mini Kit (Qiagen). The isolated 
genomic DNA was used as a template for PCR amplifi-
cation of the AQP1 promoter region. According to the 
genomic structure information for the AQP1 gene, the 
first base in the AQP1 coding sequence was numbered 
+ 1. The AQP1 primer sequences were TTA CGC GTG 
CTA GCC CGG GCC TGC ACT TAG CAG AAG CTT 
CTG GCC AG (upstream primer) and GCT TAC TTA 
GAT CGC AGA TCA TGA AGA CAA AGA GGG TCG 
TGG CCA GG (downstream primer). The digested DNA 
fragments were ligated into a pGL3-Basic plasmid (Pro-
mega, Madison, USA). After verification via sequencing, 
the successfully constructed vector was named pGL3-
AQP1-4K. Using pGL3-AQP1-4K, a series of luciferase 
reporter vectors containing various truncated forms of 
the AQP1 promoter were further constructed and named 
pGL3-AQP1-1K, pGL3-AQP1-2K, pGL3-AQP1-3K, 
pGL3-AQP1-2.2K, pGL3-AQP1-2.3K, pGL3-AQP1-2.4K, 
pGL3-AQP1-2.6K, pGL3-AQP1-2.8K, and pGL3-AQP1-
2-3K. Using pGL3-AQP1-2.3K as the template and a 
QuikChange Lightning Site-Directed Mutagenesis Kit, 
a luciferase reporter vector containing a mutated AQP1 
promoter fragment (pGL3-AQP1-2.3K mutant) was 
established. Additionally, the 0-1K and 2-3K regions 
in the AQP1 promoter were amplified via PCR. Subse-
quently, overlap PCR was performed to construct the 
pGL3-AQP1-3Δ2K vector.
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Transfection of oligonucleotides
The EGR1, FOXL1, KLF5, NFIC, RFX5, SP1, THAP1, 
SPIB, and AQP1 siRNA duplexes and negative control 
(scrambled, has no significant sequence similarity to 
mouse, rat, or human gene sequences) were designed and 
synthesized by RiboBio (Guangzhou, China). For each 
cell of a six-well plate, cells were transfected with a pool 
of three siRNAs in a total volume of 5 μl (20 μM) and 5 μl 
Lipofectamine 2000.
HEK-293T cells were first seeded into 96-well plates at 
a density of 5 × 103 cells per well 24 h before transfection. 
The cells were transfected with a mixture of 50  ng fire-
fly luciferase reporter and 5 ng pRL-CMV Renilla lucif-
erase reporter using Lipofectamine 2000. The transfected 
HEK-293T cells were used in the subsequent assays.
Examination of luciferase activity
Twenty-four hours after transfection, the cells were cov-
ered with serum-free medium and cultured for an addi-
tional 24  h. Subsequently, the cells were incubated in 
culture medium with different pH values for 6  h. The 
firefly and Renilla luciferase activities of the cell lysates 
were measured using a Dual-Luciferase Reporter Assay 
System according to the manufacturer’s instructions 
(Promega). All activity values were normalized to those 
of the control vector pGL-basic 3.0 at pH 7. The results 
were assessed based on changes in the luciferase activity. 
All experiments were repeated three times.
Chromatin immunoprecipitation (ChIP)
HEK-293T cells were first seeded into 10-cm dishes and 
then transfected with plasmids the next day when the 
cells reached approximately 40% confluence using Lipo-
fectamine 2000. For the ChIP assay, 4 × 106 cells were 
prepared using a SimpleChIP Enzymatic Chromatin IP 
kit (Cell Signaling Technology) according to the manu-
facturer’s instructions. Briefly, HEK-293T cells were fixed 
with 1% formaldehyde for 10  min at room temperature 
followed by glycine. Lysates were then digested with mic-
rococcal nuclease into DNA/proteins fragments. Anti-
flag or control IgG antibody was added, and the complex 
were co-precipitates and captured by protein G magnetic 
beads. After an overnight incubation at 4  °C, the com-
plexes were purified, and the crosslinking was reversed at 
65 °C. The resulting precipitated DNA samples were ana-
lyzed by PCR or real-time PCR using the primers listed 
in Additional file 1: Table S1.
Statistical analysis
Each group of experiments was repeated three times or 
more. Each time, three replicate wells were prepared. The 
measurement data were expressed as the mean ± stand-
ard error of the mean (SEM). Unless otherwise noted, 
Student t test (two-tailed) and one-way analysis of vari-
ance (ANOVA) followed by the Dunnett multiple com-
parisons test were used to compare differences between 
2 groups and more than 2 groups, respectively. Two-way 
ANOVA was used to analyse the luciferase activity and 
AQP1 mRNA levels in HEK-293T cells with different pH 
treatment. A P value less than 0.05 indicated that the dif-
ference was statistically significant. The above statistical 
analyses were conducted using GraphPad software, and 
the results were plotted.
Results
Effect of pH on AQP1 expression
To investigate the regulatory effects of pH on AQP1 gene 
expression, HEK-293T cells were first used as a research 
tool to examine whether AQP1 mRNA levels were upreg-
ulated at certain pH levels. HEK-293T cells grown to 
confluence with regular culture medium were exposed 
to serum-free bicarbonate-buffered medium for 24  h, 
and the pH was adjusted to 6, 7 or 8 by the addition of 
HCl or NaOH. Quantitative PCR demonstrated a sig-
nificant upregulation of AQP1 expression with pH, with 
two-fold higher mRNA levels at pH 8 than those at pH 6 
(P = 0.0009, one way ANOVA, Fig. 1a).
Genomic structure of the AQP1 gene and construction 
of luciferase reporter vectors containing AQP1 promoter 
regions
The upstream region of the AQP1 gene was analysed 
using the UCSC Genome Browser database. According to 
existing knowledge, we hypothesized that a 4-kb region 
upstream of the AQP1 gene is the transcriptional regu-
latory region and contains binding sites for transcription 
factors. Therefore, we used HEK-293T genomic DNA 
as a template to clone the 4-kb upstream region of the 
AQP1 gene lying between −  4000 and 0 base pairs (bp; 
the first base in the AQP1 coding sequence was denoted 
as + 1). The resulting 4000-bp fragment was ligated into 
a pGL3-Basic vector to establish a luciferase reporter 
vector containing the potential AQP1 promoter region 
(pGL3-AQP1-4K). The luciferase activity of pGL3-AQP1-
4K and the regulatory effects of pH on luciferase activity 
are shown in Fig. 1b. High pH upregulated the luciferase 
activity of pGL3-AQP1-4K in HEK-293T cells.
Identification of the AQP1 gene upstream promoter region
We constructed a series of luciferase reporter vectors 
containing different regions of the potential AQP1 pro-
moter. HEK-293T cells were transiently transfected with 
the reporter plasmids, and the promoter activity of the 
regions was examined using a dual-luciferase reporter 
assay. The HEK-293T cells transfected with the luciferase 
reporter vector containing the AQP1 gene upstream 
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region between − 3000 and 0 bp displayed strong lucif-
erase activity (Fig.  2a, b). Additionally, cells transfected 
with pGL3-AQP1-3K showed increased luciferase activ-
ity in response to an increase in pH. The results indicated 
a critical role for the 3-kb upstream region (−  3000 to 
0  bp) in maintaining AQP1 promoter activity and dem-
onstrated that a pH-responsive region is located between 
−  3000 and −  2000  bp. Furthermore, transfection of 
HEK-293T cells with a series of luciferase reporter vec-
tors containing various segments of the region between 
−  3000 and −  2000  bp demonstrated that the region 
between −  2300 and −  2200  bp is critical for the pH-
mediated regulation of AQP1 gene expression. Moreover, 
the region between − 1000 and 0 bp was also required to 
initiate AQP1 gene transcription (Fig. 2c–f).
Prediction of transcription factors that interact with the 
enhancer region in the AQP1 gene (− 2300 to − 2200 bp)
We predicted transcription factors that were likely to 
bind to the enhancer region (−2300 to −  2200  bp) in 
the AQP1 gene using the JASPAR database. The pre-
dicted transcription factors were regulatory factor X5 
(RFX5), early growth response 1 (EGR1), Krueppel-like 
factor 5 (KLF5), SP1, THAP domain-containing apop-
tosis-associated protein 1 (THAP1), E74-like factor 5 
(ELF5), ETS homologous factor (EHF), Spi-B transcrip-
tion factor (SPIB), nuclear factor I-C (NFIC), T cell 
leukaemia homeobox  1 (TLX1) and forkhead box L1 
(FOXL1). Next, we transfected HEK-293T cells with siR-
NAs against the 11 transcription factors identified. At 
48  h after transfection, RNA was collected and reverse 
transcribed into cDNA. The interference efficiency of 
each siRNA was determined. The ELF5, EHF and TLX1 
genes were not expressed in HEK-293T cells, and the 
expression of the other 8 genes was significantly reduced 
after siRNA-mediated interference (Additional file  1: 
Fig S1). Furthermore, HEK-293T cells were transiently 
co-transfected with siRNAs against the 8 genes and the 
luciferase reporter vector containing the 2.3-kb region 
between −  2300 and 0  bp. Subsequently, the cells were 
exposed to different pH levels, and changes in the lucif-
erase activity were examined. The results showed that 
changes in pH failed to induce corresponding changes in 
luciferase activity after siRNA-mediated downregulation 
of SP1, SPIB and THAP1 (Fig. 3a).
SPIB is a potential transcription factor capable 
of influencing pH‑regulated AQP1 expression
JASPAR predicted a number of SP1 and THAP1 binding 
sites in the AQP1 promoter region between − 1000 and 
0 bp. However, no SPIB binding sites were detected. We 
interfered the expression of the three transcription fac-
tors by siRNA and found that the expression of AQP1 
could be inhibited by knockdown of SP1 and THAP1, 
but not by knockdown of SPIB (Additional file 1: Fig S2). 
However, the pH-mediated upregulation of AQP1 mRNA 
expression was not observed after interference with SPIB 
gene expression (Fig. 3b). Moreover, a SPIB binding site 
was predicted in the AQP1 promoter region between 
−  2257 and −  2251  bp. Therefore, we hypothesized 
that SPIB plays a major role in pH-mediated upregula-
tion of AQP1 expression. To test this hypothesis, lucif-
erase reporter vectors were subjected to site-directed 
mutagenesis to introduce mutations into the correspond-
ing binding sites located in the AQP1 promoter region 
between −  2300 and 0  bp. Subsequently, HEK-293T 
cells were transfected with the corresponding luciferase 
reporter vectors (wild-type or mutant, Fig. 4a), cultured 
and exposed to various pH stimuli. The dual-luciferase 
activities were then examined in the transfected cells. As 
shown in Fig. 4b, increased pH resulted in upregulation 
of luciferase activity from the reporter vector contain-
ing wild-type AQP1-2.3k (WT). In contrast, increased 
pH had no significant effect on the luciferase activity of 
Fig. 1 Increased pH elevates AQP1 expression. a AQP1 mRNA levels in HEK-293T cells with various pH treatments. b Luciferase activity in HEK-293T 
cells transfected with firefly luciferase reporter plasmids containing AQP1 upstream regions. The Renilla luciferase reporter was co-transfected with 
pGL3-basic or a plasmid reporter. The data represent the mean ± SEM. ns no statistical significance; *P < 0.05; **P < 0.01; ***P < 0.001
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Fig. 2 Identification of the AQP1 gene upstream promoter region. a, c and e Schematic representation of human AQP1 promoter reporter con-
structs. Fragments with various lengths of the AQP1 promoter region between − 4000 to 0 bp were cloned downstream of the firefly luciferase 
reporter. b, d and f Luciferase activity in HEK-293T cells transfected with firefly luciferase reporter plasmids containing various AQP1 upstream 
regions. The Renilla luciferase reporter was co-transfected with pGL3-basic or a plasmid reporter. The data represent the mean ± SEM. **P < 0.01; 
***P < 0.001
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Fig. 3 Transcription factors interacting with the enhancer region of the AQP1 gene. a Luciferase activity associated with the region between − 2.3k 
and 0 bp in AQP1 in HEK-293T cells transfected with small interfering RNAs (siRNAs) against EGR1, FOXL1, KLF5, NFIC, RFX5, SP1, THAP1, or SPIB or 
with a negative control (NC). b AQP1 mRNA levels in HEK-293T cells after SPIB knockdown and treatment at pH 7 and 8 were assessed with real-
time PCR. The data represent the mean ± SEM. ns no statistical significance; ***P < 0.001
Fig. 4 SPIB is a potential transcription factor capable of influencing pH-regulated AQP1 expression. a Putative SPIB binding site in the region 
between − 2300 to − 2200 bp upstream of AQP1. b Firefly luciferase activity normalized to Renilla luciferase activity in HEK-293T cells co-trans-
fected with luciferase reporters with the wild-type or mutant AQP1 promoter after treatment at pH 7 or 8. c Chromatin immunoprecipitation (ChIP) 
in HEK293T cells, followed by real-time PCR amplification of the binding site within the AQP1 promoter region. d ChIP assays for the binding site in 
the AQP1 promoter were performed in HEK293T cells under different pH conditions. The data represent the mean ± SEM. ns no statistical signifi-
cance; ***P < 0.001
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the reporter vector containing the mutant AQP1-2.3k 
(MT). The results indicated that the site located in the 
AQP1 promoter region between − 2257 and − 2251 bp 
was activated in a pH-dependent manner. Chromatin 
immunoprecipitation (ChIP) assays of HEK-293T cells 
revealed that SPIB could bind to this region (Fig. 4c). Fur-
thermore, an increase in pH caused a dramatic increase 
in SPIB at the AQP1 promoter (Fig. 4d), which indicated 
that SPIB is recruited to the AQP1 promoter as a DNA-
binding complex.
We further determined whether SPIB regulates the 
AQP1 promoter, which contains a potential SPIB binding 
site. SPIB overexpression in HEK-293T cells increased 
the activity of the wild-type AQP1 promoter but not the 
mutant AQP1 promoter and increased AQP1 mRNA 
expression (Additional file 1: Fig. S3, Fig. 5). These results 
demonstrated that SPIB might be a transcription factor 
capable of affecting the pH-regulated expression of the 
AQP1 gene.
Discussion
Our previous study demonstrated that a new bicarbo-
nate-based PD solution enhances the migratory capac-
ity and damage-repair ability of human peritoneal 
mesothelial cells by upregulating AQP1, thereby playing 
an important role in protecting the functional integrity 
of the peritoneum. AQP1 forms ultra-small pores in the 
peritoneum, is responsible for transporting water across 
cell membranes [17, 18] and mediates 50% of perito-
neal ultrafiltration activities [14, 19]. Therefore, AQP1 
is essential for maintaining PD [15, 20]. In recent years, 
other important biological effects of AQP1 have also 
been discovered, including its ability to promote cell 
migration, wound healing, tumour growth and metasta-
sis and  CO2 transport across the cell membrane [21–26]. 
Clearly, a variety of important biological therapeutic 
effects can be achieved by regulating AQP1. For example, 
downregulation of AQP1 inhibits tumour blood vessel 
proliferation and tumour metastasis and reduces cerebral 
oedema. Increased AQP1 gene expression improves the 
ultrafiltration function of the peritoneum [20] enhances 
the migratory and repair capabilities of peritoneal cells 
[16] and should therefore maintain the integrity of the 
peritoneum, thereby prolonging the time until PD fail-
ure. Thus, studying AQP1 gene expression regulation is of 
great significance.
AQP1 gene expression is regulated by a variety of fac-
tors, including glucocorticoids [27], hydrostatic pres-
sure [12] and hypoxia [28]. The promoter region in the 
AQP1 gene contains the glucocorticoid [27] and hyper-
tonicity response element (GRE and HRE, respectively) 
[29–32], which upregulate AQP1 expression in response 
to glucocorticoid treatment and increasing hypertonic-
ity and hyperoncoticity. Hypoxia-inducible factor 1-alpha 
(HIF-1α) binds to the AQP1 promoter and is involved 
in hypoxia-induced AQP1 gene expression [33, 34]. We 
now provide evidence that in addition to these regulatory 
mechanisms governing AQP1 gene expression, the AQP1 
promoter contains a pH-sensitive region that upregulates 
AQP1 expression in response to increasing pH.
The present study first successfully replicated the find-
ings of our previous study using the HEK-293T cell line 
as a research tool. AQP1 mRNA levels were gradually 
elevated in HEK-293T cells as the pH increased; this 
behaviour closely resembles the regulatory effects of pH 
on AQP1 gene expression in peritoneal mesothelial cells. 
Fig. 5 AQP1 is regulated by SPIB. a Luciferase activity associated with the region between −2300 and −2200 bp in HEK-293T cells transfected with 
SPIB. b AQP1 mRNA levels in HEK-293T cells transfected with SPIB. The data represent the mean ± SEM. ns no statistical significance; ***P < 0.001
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This result indicates that AQP1 regulation at the gene 
transcriptional level is affected by pH. Then, the key tran-
scription factors and their binding sites involved in the 
pH-mediated regulation of AQP1 gene expression were 
explored. The region between −  2300 and −  2200  bp 
was critical for the pH-induced regulation of AQP1 gene 
expression. By combining the above findings with JAS-
PAR predictions and the experimental data obtained 
from the siRNA-mediated interference of gene expres-
sion and mutagenesis of the binding sites, we identi-
fied SPIB as a potential transcription factor that affects 
pH-mediated regulation of AQP1 gene expression. SPIB 
binds to the PU-box (5′-GAGGAA-3′) and activate tran-
scription of a reporter plasmid containing PU boxes [35]. 
SPIB has been reported to be involved in differentiation 
and maturation of plasmacytoid dendritic cells and to 
inhibit the differentiation of T, B and natural killer (NK) 
cells [36, 37]. PD solutions with a physiological pH may 
increase AQP1 gene expression and enhance peritoneal 
ultrafiltration by activating SPIB. Additionally, activated 
SPIB may participate in inhibition of inflammatory cell 
activation and reduction of inflammatory stimulation in 
the peritoneum, thereby achieving long-term protection 
of peritoneal function.
In the present study, we demonstrated that the pH-
mediated upregulation of AQP1 gene expression was not 
observed after interference with SPIB gene expression, 
which indicates that SPIB is involved in pH-mediated 
regulation of AQP1 expression. Furthermore, we found 
that SP1 and THAP1 also affected the luciferase activity 
induced by pH. However, knockdown of SP1 and THAP1 
inhibited the mRNA expression of AQP1, while knock-
down of SPIB had no such effect. These results indicated 
that SPIB may play a major role in the pH-mediated 
upregulation of AQP1. The regulatory effect of SP1 and 
THAP1 on the mRNA expression of AQP1 need further 
investigation. Transcription factors activity are tightly 
regulated through many ways, such as transcriptional 
control, post-transcriptional modification, transcrip-
tional co-activators and co-repressors, and interaction 
with enhancer. Using real-time qPCR and western blot 
analysis, we showed that different pH levels (pH 7 and 
pH 8) did not have significant effects on SPIB expression 
(Additional file 1: Fig S4), which indicates that pH-medi-
ated activation of AQP1 transcription does not occur 
through the increase of SPIB protein level. Enhancers and 
their associated factors can regulate expression of genes 
located far upstream and downstream by looping to the 
promoters of these genes. The interaction of AQP1 pro-
moter and SPIB protein may engender specific enhancer-
gene interaction and are essential for AQP1 activation 
mediated by pH. However, additional experiments are 
needed to better define the role of pH-mediated SPIB 
activation.
Conclusions
In summary, the present study demonstrated that a 
region upstream of the AQP1 gene (− 2300 to − 2200 bp) 
contains an enhancer required for pH-mediated reg-
ulation of AQP1 gene expression. SPIB is a specific 
transcription factor that participates in pH-mediated reg-
ulation of AQP1 gene expression. The present study facil-
itates further elucidation of the mechanisms by which 
pH regulates AQP1 gene expression and the molecu-
lar mechanisms by which pH and buffer compounds in 
PD solutions affect peritoneal membrane integrity and 
function.
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